Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia.

Hiroshi KobayashiSho MatsubaraChiharu YoshimotoHiroshi ShigetomiShogo Imanaka

Published in: Biomedicines (2023)

TFPI protein family may affect both the anticoagulant (i.e., TFPI1) and antifibrinolytic/procoagulant (i.e., TFPI2) systems. TFPI1 and TFPI2 may function as new predictive biomarkers for preeclampsia and navigate precision therapy.

Keyphrases

early onset
atrial fibrillation
pregnancy outcomes
venous thromboembolism
stem cells
climate change
binding protein
amino acid
smoking cessation